In summary, TGR5 activation can inhibit the proliferation and migration of gastric cancer cells via the suppression of STAT3 and NF-κB signal pathways, and thus TGR5 could be used to diagnose and treat gastric cancer in the future (Figure 5). This evidence concerns the gene STAT3 and gastric cancer.